Chapter 16 - The Name Nathan WroteThe name was David Keller.
Margaret read it twice.
Claire stared.
“No.”
David Keller was Nathan's former chief financial officer.
After Nathan died, David left Avery Biomedical and joined Novaline—the company now trying to merge with Avery Biomedical.
He was helping negotiate the deal from the other side.
Margaret felt sick.
Grant's merger partner.
Nathan's letter continued.
Grant thinks David is his rival. He isn't. They have been moving money together.
Claire whispered,
“I trusted David.”
Everyone did.
David had spoken at Nathan's funeral.
Helped establish scholarships in his name.
Sent birthday gifts to Theo and Nora.
Grant's fraud looked like one man's greed.
Nathan suspected a partnership.
Why had investigators not seen payments?
Because David operated through Novaline-linked research vendors overseas.
The “consulting” money leaving Avery Biomedical wasn't only returning to Grant.
Some financed patent positions and merger leverage through David.
If Grant made eighty-four million, what did David make?
Potentially more.
The merger itself may have been designed around undervaluing NORA assets.
If Claire licensed patents cheaply under pressure, Novaline would acquire technology worth hundreds of millions for far less.
Grant got personal payout.
David got corporate profit and stock compensation.
The scheme was bigger.
Nathan's letter:
If I die before I can finish, do not accuse David directly. He is more careful than Grant.
Margaret looked at Ruiz.
“He knew.”
“Suspected.”
Important distinction.
Evidence still needed.
David Keller was currently in Zurich.
Or so his public calendar said.
Federal agents contacted Swiss authorities.
Travel records showed he left Zurich two days earlier.
Destination Los Angeles.
He was here.
Where?
Novaline maintained a temporary executive residence in Beverly Hills.
Empty.
His corporate office suite.
Empty.
Then David called Claire.
She stared at her phone.
Answered on speaker.
“David.”
“Claire.”
His voice sounded warm.
Concerned.
Exactly as always.
“I heard about Grant.”
“You heard?”
“It's all over company channels.”
“Where are you?”
“Zurich.”
Lie.
Claire looked at Ruiz.
“What do you want?”
“To make sure you're safe.”
Claire almost laughed.
“Are you?”
Pause.
“Of course.”
“Then why did Nathan write Margaret a letter saying you and Grant were stealing together?”
Silence.
For the first time, David's warmth disappeared.
“You should be careful with Nathan's late-stage suspicions.”
Claire closed her eyes.
There.
Same tactic.
Nathan was sick.
Claire was unstable.
Margaret forgetful.
Children emotional.
Anyone challenging them became medically or emotionally unreliable.
“Nathan was lucid.”
“Sometimes.”
“Where are you?”
“Zurich.”
Ruiz mouthed: keep talking.
Claire said,
“Grant is in custody.”
“I know.”
“He'll talk.”
Another pause.
David laughed softly.
“Grant talks too much even when he isn't arrested.”
Not denial.
“What did you do?”
“Claire.”
“What did you do?”
“I helped build value Nathan didn't understand.”
There it was.
“By stealing?”
“No.”
“By hiding transfers?”
“Strategic positioning.”
Claire laughed.
She couldn't help it.
“What?”
“You all have different professional words for stealing.”
David's voice hardened.
“You inherited a company you don't understand.”
“I didn't inherit the company.”
“You control what matters.”
“NORA.”
“Yes.”
“That's what this is about.”
“It is about preventing Nathan's sentimental guilt from destroying billions in enterprise value.”
Margaret stared.
Sentimental guilt.
Robert Bennett.
NORA.
David believed Nathan's restitution trust was economically irrational.
Claire asked,
“So you helped Grant have me committed?”
“No.”
Immediate.
Too immediate.
“You knew?”
Silence.
“I knew he was trying to remove you from decisions.”
“How?”
“I advised him that the board needed stability.”
“Did you know about Rosemont?”
“No.”
Possible lie.
“Beatrice?”
“I knew she had debt.”
“Rachel?”
Another pause.
“Grant handled legal.”
David kept distance.
Careful.
Nathan had warned.
Then Claire said,
“Where is the original Novaline valuation?”
Silence.
Ruiz looked at her.
Smart.
A merger requires valuation models.
If David and Grant were undervaluing NORA, original internal valuation could prove intent.
David answered,
“You don't need it.”
“So it exists.”
No response.
Claire continued.
“Grant says NORA is worth one hundred eighteen million.”
David laughed.
“Grant doesn't know what it's worth.”
Claire stopped breathing.
“What is it worth?”
David said nothing.
“David.”
Finally:
“Closer to four hundred.”
The room went silent.
He realized too late.
Claire whispered,
“You were buying four hundred million dollars in patent rights for what?”
No answer.
“Forty?”
Silence.
“Fifty?”
He hung up.
Ruiz stared.
“He just gave us motive.”
And perhaps evidence if call admissible.
Federal agents moved on David's known locations.
Then an anonymous file arrived in Claire's email.
Sender untraceable at first.
Attachment:
Novaline internal valuation.
NORA IP estimated at $412 million.
Who sent it?
A note:
Nathan was right. I should have spoken sooner. — S.P.
Samuel Price.
Former CFO.
He had copies.
Why now?
Because he had also been silent for years.
He called Margaret.
“I was afraid.”
She almost laughed.
“At least everyone is consistent.”
Samuel admitted David approached him years earlier.
Suggested Nathan undervalued company contributions by funding NORA.
Samuel refused to help.
But he didn't expose David.
Retired instead.
“I told myself leaving was enough.”
“It wasn't.”
“I know.”
The valuation gave prosecutors ammunition.
Then agents located David.
Not hiding.
At Avery Biomedical headquarters.
He had entered through a board-member guest credential before sunrise.
What was he doing?
Server room.
Deleting files.
Security locked him inside remotely.
Agents arrested him without incident.
On his laptop:
Draft emails blaming all financial fraud on Grant.
Grant had planned to blame Beatrice.
David planned to blame Grant.
Every layer designed to sacrifice the person below.
Claire watched David being led out.
Then Ruiz approached with one final recovered document.
“Claire.”
“What?”
“David had a copy of Nathan's last NORA amendment.”
Rachel's original wasn't unique.
“Why?”
“He planned to forge it.”
“How?”
“Replace the trust protector.”
“Luis?”
“Yes.”
“With who?”
Ruiz showed her.
Proposed protector:
David Keller.
If successful, David could freeze or approve licensing himself.
Grant thought he was stealing a merger payout.
David intended to take control after Grant did the dirty work.
Claire looked at Margaret.
“Grant wasn't the top.”
“No.”
“David was.”
Margaret shook her head.
“No.”
Claire frowned.
“What?”
“The top wasn't a person.”
Everyone waited.
Margaret looked at the years of hidden letters, debts, medical lies, forged files, silence, resentment.
“The thing at the top was everybody believing the next secret was safer than the truth.”
Nobody argued.
But the legal case was not over.
Because David's laptop contained one folder labeled:
PASADENA INCIDENT — CONTINGENCY.
Inside were photographs of Theo.
Nora.
Luis.
The sofa.
The entrance hall.
Taken before Margaret arrived.
Beatrice's assault had not been spontaneous.
May you like
David knew it would happen.
And somebody inside the mansion had been photographing the children in real time.
Related Stories
